发明名称 |
Compositions and methods for the treatment of meibomian gland dysfunction |
摘要 |
Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from meibomian gland dysfunction. |
申请公布号 |
US9463201(B2) |
申请公布日期 |
2016.10.11 |
申请号 |
US201514732622 |
申请日期 |
2015.06.05 |
申请人 |
M.G. THERAPEUTICS LTD |
发明人 |
Alster Yair;Rafaeli Omer;Macfarlane K. Angela;Reich Cary;Amselem Shimon;Friedman Doron |
分类号 |
A61K8/23;A61K33/04;A61K31/60;A61K9/00;A61K31/327 |
主分类号 |
A61K8/23 |
代理机构 |
Wilson, Sonsini, Goodrich & Rosati |
代理人 |
Wilson, Sonsini, Goodrich & Rosati |
主权项 |
1. A method for treating meibomian gland dysfunction in a patient in need thereof, comprising topically administering to the patient a composition that reaches the eyelid margin of the patient, wherein the composition comprises a therapeutically-effective amount of at least one keratolytic agent in an ophthalmically-acceptable carrier, wherein the keratolytic agent is an inorganic selenium compound, or an organo-selenium compound. |
地址 |
Tel Aviv IL |